Milestone Pharmaceuticals Inc.MISTNASDAQ
Loading
Other Income/Expenses (Net) Over TimeContracting
Percentile Rank29
3Y CAGR+38.4%
5Y CAGR-25.8%
Year-over-Year Change

Net other income and expenses outside core operations

3Y CAGR
+38.4%/yr
vs +4.3%/yr prior
5Y CAGR
-25.8%/yr
Recent acceleration
Acceleration
+34.1pp
Accelerating
Percentile
P29
Within normal range
vs 5Y Ago
0.2x
Contraction
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
2024$583000.00-58.7%
2023$1.41M+12.7%
2022$1.25M+470.0%
2021$220000.00-69.7%
2020$726000.00-72.0%
2019$2.60M+265.1%
2018$711000.00+282.3%
2017$186000.00-